Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| green tea - Escherichia coli H30 |
👶
Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli. Frontiers in microbiology (Front Microbiol ) Vol: 4 Issue Pages: 162 Pub: 2013 Epub: 2013 Jun 18 Authors Reygaert W , Jusufi I , Html Article Publication |
| green tea - Escherichia coli H30 |
👶
AFM probing the mechanism of synergistic effects of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. PloS one (PLoS One ) Vol: 7 Issue 11 Pages: e48880 Pub: 2012 Epub: 2012 Nov 13 Authors Cui Y , Kim SH , Kim H , Yeom J , Ko K , Park W , Park S , Html Article Publication |
| green tea - Escherichia coli H30 |
👶
Antioxidant and antibacterial properties of green, black, and herbal teas of Camellia sinensis. Pharmacognosy research (Pharmacognosy Res ) Vol: 3 Issue 4 Pages: 266-72 Pub: 2011 Oct Epub: Authors Chan EW , Soh EY , Tie PP , Law YP , Html Article Publication |
| green tea - Escherichia coli H30 |
👶
Selenium-enriched green tea extracts: chemical constituents and effects on antioxidant and anti-inflammatory factors and four major intestinal flora in mice with intestinal disorders. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: Issue Pages: Pub: 2025 Apr 15 Epub: 2025 Apr 15 Authors Yang H , Tao H , Xu C , Song J , Teng C , Pan C , Wei S , Publication |
| green tea - Escherichia coli H30 |
👶
Effect of hydrophobic property on antibacterial activities of green tea polysaccharide conjugates against Escherichia coli. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 253 Issue Pt 1 Pages: 126583 Pub: 2023 Dec 31 Epub: 2023 Aug 29 Authors Zhou Y , Liu W , Cao W , Cheng Y , Liu Z , Chen X , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
